These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators. Nagarajan P; Chin SS; Wang D; Liu S; Sinha S; Garrett-Sinha LA J Cell Sci; 2010 Oct; 123(Pt 20):3566-75. PubMed ID: 20930145 [TBL] [Abstract][Full Text] [Related]
3. Propofol suppresses gastric cancer tumorigenesis by modulating the circular RNA‑PVT1/miR‑195‑5p/E26 oncogene homolog 1 axis. Sui H; Zhu C; Li Z; Yang J Oncol Rep; 2020 Oct; 44(4):1736-1746. PubMed ID: 32945521 [TBL] [Abstract][Full Text] [Related]
4. ETS1 regulates Twist1 transcription in a Kras Millien G; Cao Y; O'Hara CJ; Tagne JB; Hinds A; Williams MC; Ramirez MI; Kathuria H Clin Exp Metastasis; 2018 Mar; 35(3):149-165. PubMed ID: 29909489 [TBL] [Abstract][Full Text] [Related]
5. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells. Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression. Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Yu H; Qi L J Exp Clin Cancer Res; 2019 Dec; 38(1):486. PubMed ID: 31823805 [TBL] [Abstract][Full Text] [Related]
7. The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. Delannoy-Courdent A; Mattot V; Fafeur V; Fauquette W; Pollet I; Calmels T; Vercamer C; Boilly B; Vandenbunder B; Desbiens X J Cell Sci; 1998 Jun; 111 ( Pt 11)():1521-34. PubMed ID: 9580560 [TBL] [Abstract][Full Text] [Related]
8. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors. Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340 [TBL] [Abstract][Full Text] [Related]
9. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells. Sinh ND; Endo K; Miyazawa K; Saitoh M Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944 [TBL] [Abstract][Full Text] [Related]
10. Expression of ETS1 in gastric epithelial cells positively regulate inflammatory response in Helicobacter pylori-associated gastritis. Teng Y; Cang B; Mao F; Chen W; Cheng P; Peng L; Luo P; Lu D; You N; Zou Q; Zhuang Y Cell Death Dis; 2020 Jul; 11(7):498. PubMed ID: 32612120 [TBL] [Abstract][Full Text] [Related]
11. ETS1 induction by the microenvironment promotes ovarian cancer metastasis through focal adhesion kinase. Tomar S; Plotnik JP; Haley J; Scantland J; Dasari S; Sheikh Z; Emerson R; Lenz D; Hollenhorst PC; Mitra AK Cancer Lett; 2018 Feb; 414():190-204. PubMed ID: 29174800 [TBL] [Abstract][Full Text] [Related]
12. An Rb1-dependent amplification loop between Ets1 and Zeb1 is evident in thymocyte differentiation and invasive lung adenocarcinoma. Dean KC; Huang L; Chen Y; Lu X; Liu Y BMC Mol Biol; 2015 Mar; 16():8. PubMed ID: 25880398 [TBL] [Abstract][Full Text] [Related]
13. The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus. Kim CJ; Lee CG; Jung JY; Ghosh A; Hasan SN; Hwang SM; Kang H; Lee C; Kim GC; Rudra D; Suh CH; Im SH Immunity; 2018 Dec; 49(6):1034-1048.e8. PubMed ID: 30566881 [TBL] [Abstract][Full Text] [Related]
14. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming. Bhattacharya R; Ray Chaudhuri S; Roy SS J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943 [TBL] [Abstract][Full Text] [Related]
15. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961 [TBL] [Abstract][Full Text] [Related]
16. ETS1 targets RYBP transcription to inhibit tumor cell proliferation. Zhao W; Zhang S; Wang X; Ma X; Huang B; Chen H; Chen D Biochem Biophys Res Commun; 2019 Feb; 509(3):810-816. PubMed ID: 30638661 [TBL] [Abstract][Full Text] [Related]
17. Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma. Gluck C; Glathar A; Tsompana M; Nowak N; Garrett-Sinha LA; Buck MJ; Sinha S PLoS Genet; 2019 Jul; 15(7):e1008250. PubMed ID: 31306413 [TBL] [Abstract][Full Text] [Related]
18. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer. Xu S; Ge J; Zhang Z; Zhou W Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829 [TBL] [Abstract][Full Text] [Related]
19. miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1. Wang R; Ma Y; Yu D; Zhao J; Ma P Biomed Pharmacother; 2015 Mar; 70():64-71. PubMed ID: 25776481 [TBL] [Abstract][Full Text] [Related]
20. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]